We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+14.15%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$15.9B
AUM Growth
+$2.13B
Cap. Flow
+$466M
Cap. Flow %
2.92%
Top 10 Hldgs %
24.56%
Holding
2,169
New
258
Increased
811
Reduced
944
Closed
131

Sector Composition

Rank Sector Weight
1 Technology 17.06%
2 Financials 11.7%
3 Healthcare 8.92%
4 Consumer Discretionary 8.64%
5 Industrials 5.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PVG
776
DELISTED
PRETIUM RESOURCES INC.
PVG
$3.1M 0.02%
270,231
+52,265
+24% +$629K
PBCT
777
DELISTED
People's United Financial Inc
PBCT
$3.09M 0.02%
239,131
+54,537
+30% +$656K
GAP
778
The Gap Inc
GAP
$7.37B
$3.08M 0.02%
152,622
-70,099
-31% -$1.47M
AIG icon
779
American International
AIG
$41.3B
$3.08M 0.02%
81,222
+4,470
+6% +$157K
HTD
780
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$900M
$3.07M 0.02%
146,079
+22,336
+18% +$457K
ROP icon
781
Roper Technologies
ROP
$39.8B
$3.07M 0.02%
7,121
+2,827
+66% +$1.16M
XYZ
782
Block Inc
XYZ
$47.5B
$3.04M 0.02%
13,992
+3,173
+29% +$619K
ISD
783
PGIM High Yield Bond Fund
ISD
$419M
$3.04M 0.02%
202,529
+11,639
+6% +$167K
GDO
784
Western Asset Global Corporate Defined Opportunity Fund
GDO
$77.4M
$3.04M 0.02%
167,696
-34,267
-17% -$598K
WST icon
785
West Pharmaceutical
WST
$24.9B
$3.03M 0.02%
10,694
+3,403
+47% +$955K
JTD
786
DELISTED
NUVEEN TAX-ADVANTAGE DIVIDEND GROWTH FUND
JTD
$3.02M 0.02%
212,284
-18,721
-8% -$249K
RH icon
787
RH
RH
$3.71B
$3.01M 0.02%
6,720
-2,556
-28% -$1.05M
NVTA
788
DELISTED
Invitae Corporation
NVTA
$3.01M 0.02%
+71,923
New +$3.44M
BNY
789
DELISTED
BlackRock New York Municipal Income Trust
BNY
$2.99M 0.02%
204,843
+4,669
+2% +$64.9K
NRG icon
790
NRG Energy
NRG
$24.8B
$2.99M 0.02%
79,525
-101,320
-56% -$3.34M
NG icon
791
NovaGold Resources
NG
$3.33B
$2.98M 0.02%
308,405
+48,040
+18% +$507K
ACP
792
abrdn Income Credit Strategies Fund
ACP
$637M
$2.98M 0.02%
281,106
-39,695
-12% -$399K
CRL icon
793
Charles River Laboratories
CRL
$12.8B
$2.98M 0.02%
11,933
+5,050
+73% +$1.2M
FSM icon
794
Fortuna Silver Mines
FSM
$3.07B
$2.97M 0.02%
360,057
+32,145
+10% +$223K
NMFC icon
795
New Mountain Finance
NMFC
$732M
$2.96M 0.02%
260,605
-58,620
-18% -$630K
DAR icon
796
Darling Ingredients
DAR
$9.44B
$2.96M 0.02%
+51,305
New +$2.45M
ACAD icon
797
Acadia Pharmaceuticals
ACAD
$5.03B
$2.95M 0.02%
55,237
-23,009
-29% -$1.14M
TCPC icon
798
BlackRock TCP Capital
TCPC
$345M
$2.95M 0.02%
262,460
-56,460
-18% -$612K
JHI
799
John Hancock Investors Trust
JHI
$117M
$2.93M 0.02%
169,662
-1,354
-0.8% -$22.4K
AME icon
800
Ametek
AME
$58.2B
$2.93M 0.02%
24,214
+7,085
+41% +$798K

Similar funds

Guggenheim Capital's Q4 2020 Portfolio in Review

As of Q4 2020, Guggenheim Capital held 2,169 positions worth $15.9B, up 15% from $13.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Guggenheim Capital's Q4 2020 filing shows 258 new, 811 increased, 944 reduced and 131 closed positions. Its largest new stake was Gores Holdings VI, Inc. Unit: 4,000,000 shares worth $42.4M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Guggenheim Capital's largest Q4 2020 buy was Gores Holdings VI, Inc. Unit: 4,000,000 shares worth $42.4M.
  • Guggenheim Capital added most to iShares Core US Aggregate Bond ETF in Q4 2020, an estimated $235M increase.
  • Guggenheim Capital's biggest Q4 2020 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $32.3M.
  • Guggenheim Capital fully exited Super Micro Computer in Q4 2020, selling an estimated $10.2M.
  • Guggenheim Capital's ten largest holdings make up 25% of its $15.9B portfolio in Q4 2020.
  • Guggenheim Capital opened 258 new positions and closed 131 in Q4 2020.
  • Guggenheim Capital's portfolio value rose 15% quarter-over-quarter to $15.9B.

Based on Guggenheim Capital's 13F filing for Q4 2020, filed 16 Feb 2021.